Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurotune AG

www.neurotune.com

Latest From Neurotune AG

Nascent Sarcopenia Pipeline’s First Target Is Myostatin

Biologics affecting myostatin signaling are at the forefront of the R&D pipeline for sarcopenia, with leading candidates in Phase II from Sanofi/Regeneron, Lilly and Novartis.

BioPharmaceutical Clinical Trials

The Blockcluster Model: An Alternate Path To Profitability

As blockbuster pipelines dwindle, some large manufacturers see building portfolios of drugs for narrow, related clusters of indications as significant market opportunities. Companies such as GSK, Genzyme, Novartis and Pfizer are finding success with assets that truly address an unmet need and have the potential to be reimbursed at a premium price. However, in many cases, the development and commercialization of narrow-indication drugs are not easy tasks.

BioPharmaceutical Strategy

New appointment at BioMedPartners

The Swiss healthcare venture capital firm, BioMedPartners, has recruited Dr Andreas Schulze as a partner, and promoted Patrick Burgermeister to principal. Dr Schulze was previously CEO of the biotech company, Neurotune, and before that headed the biotech team at the German venture capital firm, DEWB. Mr Burgermeister joined BioMedPartners in 2006 from Novartis, where he was a senior portfolio manager.

Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Neurotune AG
  • Senior Management
  • Armin W Mäder, PhD, CEO & CFO
    Jan W Vrijbloed, PhD, CSO
    Bruno Oesch, PhD, Head, Bus. Dev. & Licensing
  • Contact Info
  • Neurotune AG
    Phone: 44 200 21 95
    Wagistrasse 27 a
    Schlieren-Zurich, 8952
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register